Kooperativer Bibliotheksverbund

In: South African Journal of Psychiatry, AOSIS, Vol. 19, No. 3 ( 2013-08-30), p. 36-

Abstract: 〈 p 〉 〈 strong 〉 List of abstracts and authors: 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 1. Bipolar disorder not otherwise specified -overdiagnosed or underdiagnosed? 〈 /strong 〉 〈 /p 〉 〈 p 〉 E Allers 〈 /p 〉 〈 p 〉 〈 strong 〉 2. The prognosis of major depression untreated and treated: Does the data reflect the true picture of the prognosis of this very common disorder? 〈 /strong 〉 〈 /p 〉 〈 p 〉 E Allers 〈 /p 〉 〈 p 〉 〈 strong 〉 3. Can we prolong our patients' life expectancy? Providing a better quality of life for patients with severe mental illness 〈 /strong 〉 〈 /p 〉 〈 p 〉 O A Betencourt 〈 /p 〉 〈 p 〉 〈 strong 〉 4. The scope of ECT practice in South Africa 〈 /strong 〉 〈 /p 〉 〈 p 〉 J Benson-Martin, P Milligan 〈 /p 〉 〈 p 〉 〈 strong 〉 5. Biomarkers for schizophrenia: Can we evolve like cancer therapeutics? 〈 /strong 〉 〈 /p 〉 〈 p 〉 P Buckley 〈 strong 〉 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 6. Relapse in schizophrenis: Major challenges in prediction and prevention 〈 /strong 〉 〈 /p 〉 〈 p 〉 P Buckley 〈 /p 〉 〈 p 〉 〈 strong 〉 7. Informed consent in biological treatments: The right to know the duty to inform 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 〈 /strong 〉 I Chetty 〈 /p 〉 〈 p 〉 〈 strong 〉 8. Effectiveness of a long-acting injectable antipsychotic plus an assertive monitoring programme in first-episode schizophrenia 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 〈 /strong 〉 B Chiliza, L Asmal, O Esan, A Ojagbemi, O Gureje, R Emsley 〈 /p 〉 〈 p 〉 〈 strong 〉 9. Name, shame, fame 〈 /strong 〉 〈 /p 〉 〈 p 〉 P Cilliers 〈 /p 〉 〈 p 〉 〈 strong 〉 10. Can we manage the increasing incidence of violent raging children? We have to! 〈 /strong 〉 〈 /p 〉 〈 p 〉 H Clark 〈 /p 〉 〈 p 〉 〈 strong 〉 11. Serotonin, depression and antidepressant action 〈 /strong 〉 〈 /p 〉 〈 p 〉 P Cowen 〈 /p 〉 〈 p 〉 〈 strong 〉 12. Prevalence and correlates of comorbid psychiatris illness in patients with heroin use disorder admitted to Stikland Opioid Detoxification Unit 〈 /strong 〉 〈 /p 〉 〈 p 〉 L Dannatt, K J Cloete, M Kidd, L Weich 〈 /p 〉 〈 p 〉 〈 strong 〉 13. Investigating the association between diabetes mellitus, depression and psychological distress in a cohort of South African teachers 〈 /strong 〉 〈 /p 〉 〈 p 〉 A K Domingo, S Seedat, T M Esterhuizen, C Laurence, J Volmink, L Asmal 〈 /p 〉 〈 p 〉 〈 strong 〉 14. Neuropeptide S -emerging evidence for a role in anxiety 〈 /strong 〉 〈 /p 〉 〈 p 〉 K Domschke 〈 /p 〉 〈 p 〉 〈 strong 〉 15. Pathogenetics of anxiety 〈 /strong 〉 〈 /p 〉 〈 p 〉 K Domschke 〈 /p 〉 〈 p 〉 〈 strong 〉 16. The effects of HIV on the fronto-striatal system 〈 /strong 〉 〈 /p 〉 〈 p 〉 S du Plessis, M Vink, J Joska, E Koutsilieri, C Scheller, B Spottiswoode, D Stein, R Emsley 〈 /p 〉 〈 p 〉 〈 strong 〉 17. Effects of acute antipsychotic treatment on brain morphology in schizophrenia 〈 /strong 〉 〈 /p 〉 〈 p 〉 R Emsley, L Asmal, B Chiliza, S du Plessis, J Carr, A Goosen, M Kidd, M Vink, R Kahn 〈 /p 〉 〈 p 〉 〈 strong 〉 18. Development of a genetic database resource for monitoring of breast cancer patients at risk of physical and psychological complications 〈 /strong 〉 〈 /p 〉 〈 p 〉 K Grant, F J Cronje, K Botha, J P Apffelstaedt, M J Kotze 〈 /p 〉 〈 p 〉 〈 strong 〉 19. Unipolar mania reconsidered: Evidence from a South African study 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 〈 /strong 〉 C Grobler 〈 /p 〉 〈 p 〉 〈 strong 〉 20. Antipsychotic-induced movement disorders: Occurence and management 〈 /strong 〉 〈 /p 〉 〈 p 〉 P Haddad 〈 /p 〉 〈 p 〉 〈 strong 〉 21. The place of observational studies in assessing the effectiveness of long-acting injectable antipsychotics 〈 /strong 〉 〈 /p 〉 〈 p 〉 P Haddad 〈 /p 〉 〈 p 〉 〈 strong 〉 22. Molecular mechanisms of d-cycloserine in fear extinction: Insights from RNS sequencing 〈 /strong 〉 〈 /p 〉 〈 p 〉 S Hemmings, S Malan-Muller, L Fairbairn, M Jalali, E J Oakeley, J Gamieldien, M Kidd, S Seedat 〈 /p 〉 〈 p 〉 〈 strong 〉 23. Schizophrenia: The role of inflammation 〈 /strong 〉 〈 /p 〉 〈 p 〉 DC Henderson 〈 /p 〉 〈 p 〉 〈 strong 〉 24. Addictions: Emergent trends and innovations 〈 /strong 〉 〈 /p 〉 〈 p 〉 V Hitzeroth 〈 /p 〉 〈 p 〉 〈 strong 〉 25. The socio-cultural-religious context of biological psychiatric practice 〈 /strong 〉 〈 /p 〉 〈 p 〉 B Janse van Rensburg 〈 /p 〉 〈 p 〉 〈 strong 〉 26. Biochemical markers for identifying risk factors for disability progression in multiple sclerosis 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 〈 /strong 〉 S Janse van Rensburg, M J Kotze, F J Cronje, W Davis, K Moremi, M Jalali Sefid Dashti, J Gamieldien, D Geiger, M Rensburg, R van Toorn, M J de Klerk, G M Hon, T Matsha, S Hassan, R T Erasmus 〈 /p 〉 〈 p 〉 〈 strong 〉 27. Alcohol-induced psychotic disorder: Brain perfusion and psychopathology - before and after antipsychotic treatment 〈 /strong 〉 〈 /p 〉 〈 p 〉 G Jordaan, J M Warwick, D G Nel, R Hewlett, R Emsley 〈 /p 〉 〈 p 〉 〈 strong 〉 28.'Pump and dump': Harm reduction strategies for breastfeeding while using substances 〈 /strong 〉 〈 /p 〉 〈 p 〉 L Kramer 〈 /p 〉 〈 p 〉 〈 strong 〉 29. Adolescent neuropsychiatry - an emerging field in South African adolescent psychiatric services 〈 /strong 〉 〈 /p 〉 〈 p 〉 A Lachman 〈 /p 〉 〈 p 〉 〈 strong 〉 30. Recovery versus remission, or what it means to be healthy for a psychiatric patient? 〈 /strong 〉 〈 /p 〉 〈 p 〉 B Latecki 〈 /p 〉 〈 p 〉 〈 strong 〉 31. Holistic methods utilised to normalise behaviours in youth diagnosed with neuro-biochemical disorders 〈 /strong 〉 〈 /p 〉 〈 p 〉 P Macqueen 〈 /p 〉 〈 p 〉 〈 strong 〉 32. Candidate genes and novel polymorphisms for anxiety disorder in a South African cohort 〈 /strong 〉 〈 /p 〉 〈 p 〉 N McGregor, J Dimatelis, S M J Hemmings, C J Kinnear, D Stein, V Russel, C Lochner 〈 /p 〉 〈 p 〉 〈 strong 〉 33. Higher visual functioning 〈 /strong 〉 〈 /p 〉 〈 p 〉 A Moodley 〈 /p 〉 〈 p 〉 〈 strong 〉 34. The effects of prenatal methylmercury exposure on trace element and antioxidant levels in rat offspring following 6-hydroxydopamine-induced neuronal insult 〈 /strong 〉 〈 /p 〉 〈 p 〉 Z M Moosa, W M U Daniels, M V Mabandla 〈 /p 〉 〈 p 〉 〈 strong 〉 35. Paediatric neuropsychiatric movement disorders 〈 /strong 〉 〈 /p 〉 〈 p 〉 L Mubaiwa 〈 /p 〉 〈 p 〉 〈 strong 〉 36. The South African national female offenders study 〈 /strong 〉 〈 /p 〉 〈 p 〉 M Nagdee, L Artz, C de Clercq, P de Wet, H Erlacher, S Kaliski, C Kotze, L Kowalski, J Naidoo, S Naidoo, J Pretorius, M Roffey, F Sokudela, U Subramaney 〈 /p 〉 〈 p 〉 〈 strong 〉 37. Neurobiological consequences of child abuse 〈 /strong 〉 〈 /p 〉 〈 p 〉 C Nemeroff 〈 /p 〉 〈 p 〉 〈 strong 〉 38. What do Stellenbosch Unviversity medical students think about psychiatry - and why should we care? 〈 /strong 〉 〈 /p 〉 〈 p 〉 G Nortje, S Suliman, K Seed, G Lydall, S Seedat 〈 /p 〉 〈 p 〉 〈 strong 〉 39. Neurological soft skins in Nigerian Africans with first episode schizophrenia: Factor structure and clinical correlates 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 〈 /strong 〉 A Ojagbemi, O Esan, O Gureje, R Emsley 〈 /p 〉 〈 p 〉 〈 strong 〉 40. Should psychiatric patients know their MTHFR status? 〈 /strong 〉 〈 /p 〉 〈 p 〉 E Peter 〈 /p 〉 〈 p 〉 〈 strong 〉 41. Clinical and functional outcome of treatment refractory first-episode schizophrenia 〈 /strong 〉 〈 /p 〉 〈 p 〉 L Phahladira, R Emsley, L Asmal, B Chiliza 〈 /p 〉 〈 p 〉 〈 strong 〉 42. Bioethics by case discussion 〈 /strong 〉 〈 /p 〉 〈 p 〉 W Pienaar 〈 /p 〉 〈 p 〉 〈 strong 〉 43. Reviewing our social contract pertaining to psychiatric research in children, research in developing countries and distributive justice in pharmacy 〈 /strong 〉 〈 /p 〉 〈 p 〉 W Pienaar 〈 /p 〉 〈 p 〉 〈 strong 〉 44. The performance of the MMSE in a heterogenous elderly South African population 〈 /strong 〉 〈 /p 〉 〈 p 〉 S Ramlall, J Chipps, A I Bhigjee, B J Pillay 〈 /p 〉 〈 p 〉 〈 strong 〉 45. Biological basis addiction (alocohol and drug addiction) 〈 /strong 〉 〈 /p 〉 〈 p 〉 S Rataemane 〈 /p 〉 〈 p 〉 〈 strong 〉 46. Volumetric brain changes in prenatal methamphetamine-exposed children compared with healthy unexposed controls 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 〈 /strong 〉 A Roos, K Donald, G Jones, D J Stein 〈 /p 〉 〈 p 〉 〈 strong 〉 47. Single voxel proton magnetic resonance spectroscopy of the amygdala in social anxiety disorder in the context of early developmental trauma 〈 /strong 〉 〈 /p 〉 〈 p 〉 D Rosenstein, A Hess, S Seedat, E Meintjies 〈 /p 〉 〈 p 〉 〈 strong 〉 48. Discussion of HDAC inhibitors, with specific reference to supliride and its use during breastfeeding 〈 /strong 〉 〈 /p 〉 〈 p 〉 J Roux 〈 /p 〉 〈 p 〉 〈 strong 〉 49. Prevalence and clinical correlates of police contact prior to a first diagnosis of schizophrenia 〈 /strong 〉 〈 /p 〉 〈 p 〉 C Schumann, L Asmal, K Cloete, B Chiliza, R Emsley 〈 /p 〉 〈 p 〉 〈 strong 〉 50. Are dreams meaningless? 〈 /strong 〉 〈 /p 〉 〈 p 〉 M Solms 〈 /p 〉 〈 p 〉 〈 strong 〉 51. The conscious id 〈 /strong 〉 〈 /p 〉 〈 p 〉 M Solms 〈 strong 〉 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 52. Depression and resilience in HIV-infected women with early life stress: Does trauma play a mediating role? 〈 /strong 〉 〈 /p 〉 〈 p 〉 G Spies, S Seedat 〈 /p 〉 〈 p 〉 〈 strong 〉 53. State of affairs analysis for forensic psychiatry in SA 〈 /strong 〉 〈 /p 〉 〈 p 〉 U Subramaney 〈 /p 〉 〈 p 〉 〈 strong 〉 54. Escitalopram in the prevention of post-traumatic stress disorder: A pilot randomised controlled trial 〈 /strong 〉 〈 /p 〉 〈 p 〉 S Suliman, S Seedat, J Pingo, T Sutherland, J Zohar, D J Stein 〈 /p 〉 〈 p 〉 〈 strong 〉 55. Epigenetic consequences of adverse early social experiences in primates 〈 /strong 〉 〈 /p 〉 〈 p 〉 S Suomi 〈 /p 〉 〈 p 〉 〈 strong 〉 56. Risk, resilience, and gene x environment interactions in primates 〈 /strong 〉 〈 /p 〉 〈 p 〉 S Suomi 〈 /p 〉 〈 p 〉 〈 strong 〉 57. Biological aspects of anorexia nervosa 〈 /strong 〉 〈 /p 〉 〈 p 〉 C Szabo 〈 /p 〉 〈 p 〉 〈 strong 〉 58. Agents used and profiles of non-fatal suicidal behaviour in East London 〈 /strong 〉 〈 /p 〉 〈 p 〉 H Uys 〈 /p 〉 〈 p 〉 〈 strong 〉 59. The contributions of G-protein coupled receptor signalling to opioid dependence 〈 /strong 〉 〈 /p 〉 〈 p 〉 J van Tonder 〈 /p 〉 〈 p 〉 〈 strong 〉 60. Emerging trend and innovation in PTSD and OCD 〈 /strong 〉 〈 /p 〉 〈 p 〉 J Zohar 〈 /p 〉 〈 p 〉 〈 strong 〉 61. Making the SASOP treatment guidelines operational 〈 /strong 〉 〈 /p 〉 〈 p 〉 E Allers 〈 /p 〉 〈 p 〉 〈 strong 〉 Poster Presentations 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 62. Neuropsychological deficits in social anxiety disorder in the context of early developmental trauma 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 〈 /strong 〉 S Bakelaar, D Rosenstein, S Seedat 〈 /p 〉 〈 p 〉 〈 strong 〉 63.Social anxiety disorder in patients with or without early childhood trauma: Relationship to behavioral inhibition and activation and quality of life 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 〈 /strong 〉 S Bakelaar, C Bruijnen, A Sambeth, S Seedat 〈 /p 〉 〈 p 〉 〈 strong 〉 64. Exploring altered affective processing in obssessive compulsive disorder symptom subtypes 〈 /strong 〉 〈 /p 〉 〈 p 〉 E Breet, J Ipser, D Stein, C Lochner 〈 strong 〉 〈 br / 〉 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 65. To investigate the bias toward recognising the facial expression of disgust in obsessive compulsive disorder as well as the effect of escitalopram 〈 /strong 〉 〈 /p 〉 〈 p 〉 E Breet, J Ipser, D Stein, C Lochner 〈 /p 〉 〈 p 〉 〈 strong 〉 66. A fatal-case of nevirapine-induced Stevens-Johnson's syndrome in HIV mania 〈 /strong 〉 〈 /p 〉 〈 p 〉 A Bronkhorst, Z Zingela, W M Qwesha, B P Magigaba 〈 strong 〉 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 67. Association of the COMT G472A (met/met) genotype with lower disability in people diagnosed with multiple sclerosis 〈 /strong 〉 〈 /p 〉 〈 p 〉 W Davis, S J van Rensburg, L Fisher, F J Cronje, D Geiger, M J Kotze 〈 /p 〉 〈 p 〉 〈 strong 〉 68. Homocycsteine levels are associated with the fat mass and obesity associated gene FTO(intron 1 T & gt;A) polymorphism in MS patients 〈 /strong 〉 〈 /p 〉 〈 p 〉 W Davis, S J Van Rensburg, M J Kotze, L Fisher, M Jalali, F J Cronje, K Moremi, J Gamieldien, D Geiger, M Rensburg, R van Toorn, M J de Klerk, G M Hon, T Matsha, S Hassan, R T Erasmus 〈 /p 〉 〈 p 〉 〈 strong 〉 69. Analysis of the COMT 472 G & gt;A (rs4680) polymorphism in relation to environmental influences as contributing factors in patients with schizophrenia 〈 /strong 〉 〈 /p 〉 〈 p 〉 D de Klerk, S J van Rensburg, R A Emsley, D Geiger, M Rensburg, R T Erasmus, M J Kotze 〈 /p 〉 〈 p 〉 〈 strong 〉 70. Dietary folate intake, homocysteine levels and MTHFR mutation detection in South African patients with depression: Test development for clinical application 〈 /strong 〉 〈 /p 〉 〈 p 〉 D Delport, N vand der Merwe, R Schoeman, M J Kotze 〈 /p 〉 〈 p 〉 〈 strong 〉 71. The use ofexome sequencing for antipsychotic pharmacogenomic applications in South African schizophrenia patients 〈 /strong 〉 〈 /p 〉 〈 p 〉 B Drogmoller, D Niehaus, G Wright, B Chiliza, L Asmal, R Emsley, L Warnich 〈 /p 〉 〈 p 〉 〈 strong 〉 72. The effects of HIV on the ventral-striatal reward system 〈 /strong 〉 〈 /p 〉 〈 p 〉 S du Plessis, M Vink, J Joska, E Koutsilieri, C Scheller, B Spottiswoode, D Stein, R Emsley 〈 /p 〉 〈 p 〉 〈 strong 〉 73. Xenomelia relates to asymmetrical insular activity: A case study of fMRI 〈 /strong 〉 〈 /p 〉 〈 p 〉 S du Plessis, M Vink, L Asmal 〈 /p 〉 〈 p 〉 〈 strong 〉 74. Maternal mental helath: A prospective naturalistic study of the outcome of pregancy in women with major psychiatric disorders in an African country 〈 /strong 〉 〈 /p 〉 〈 p 〉 E du Toit, L Koen, D Niehaus, B Vythilingum, E Jordaan, J Leppanen 〈 /p 〉 〈 p 〉 〈 strong 〉 75. Prefrontal cortical thinning and subcortical volume decrease in HIV-positive children with encephalopathy 〈 /strong 〉 〈 /p 〉 〈 p 〉 J P Fouche, B Spottiswoode, K Donald, D Stein, J Hoare 〈 /p 〉 〈 p 〉 〈 strong 〉 76. H-magnetic resonance spectroscopy metabolites in schizophrenia 〈 /strong 〉 〈 /p 〉 〈 p 〉 F Howells, J Hsieh, H Temmingh, D J Stein 〈 /p 〉 〈 p 〉 〈 strong 〉 77. Hypothesis for the development of persistent methamphetamine-induced psychosis 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 〈 /strong 〉 J Hsieh, D J Stein, F M Howells 〈 /p 〉 〈 p 〉 〈 strong 〉 78. Culture, religion, spirituality and psychiatric practice: The SASOP Spirituality and Psychiatry Special Interest Group Action Plan for 2012-2014 〈 /strong 〉 〈 /p 〉 〈 p 〉 B Janse van Rensburg 〈 /p 〉 〈 p 〉 〈 strong 〉 79. Cocaine reduces the efficiency of dopamine uptake in a rodent model of attention-deficit/hyperactivity disorder: An 〈 em 〉 in vivo 〈 /em 〉 electrochemical study 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 〈 /strong 〉 L Kellaway, J S Womersley, D J Stein, G A Gerhardt, V A Russell 〈 /p 〉 〈 p 〉 〈 strong 〉 80. Kleine-Levin syndrome: Case in an adolescent psychiatric unit 〈 /strong 〉 〈 /p 〉 〈 p 〉 A Lachman 〈 /p 〉 〈 p 〉 〈 strong 〉 81. Increased inflammatory stress specific clinical, lifestyle and therapeutic variables in patients receiving treatment for stress, anxiety or depressive symptoms 〈 /strong 〉 〈 /p 〉 〈 p 〉 H Luckhoff, M Kotze, S Janse van Rensburg, D Geiger 〈 /p 〉 〈 p 〉 〈 strong 〉 82. Catatonia: An eight-case series report 〈 /strong 〉 〈 /p 〉 〈 p 〉 M Mabenge, Z Zingela, S van Wyk 〈 /p 〉 〈 p 〉 〈 strong 〉 83. Relationship between anxiety sensitivity and childhood trauma in a random sample of adolescents from secondary schools in Cape Town 〈 /strong 〉 〈 /p 〉 〈 p 〉 L Martin, M Viljoen, S Seedat 〈 /p 〉 〈 p 〉 〈 strong 〉 84. 'Making ethics real'. An overview of an ethics course presented by Fraser Health Ethics Services, BC, Canada 〈 /strong 〉 〈 /p 〉 〈 p 〉 JJ McCallaghan 〈 /p 〉 〈 p 〉 〈 strong 〉 85. Clozapine discontinuation rates in a public healthcare setting 〈 /strong 〉 〈 /p 〉 〈 p 〉 M Moolman, W Esterhuysen, R Joubert, J C Lamprecht, M S Lubbe 〈 /p 〉 〈 p 〉 〈 strong 〉 86. Retrospective review of clozapine monitoring in a publica sector psychiatric hospital and associated clinics 〈 /strong 〉 〈 /p 〉 〈 p 〉 M Moolman, W Esterhuysen, R Joubert, J C Lamprecht, M S Lubbe 〈 /p 〉 〈 p 〉 〈 strong 〉 87. Association of an iron-related TMPRSS6 genetic variant c.2007 C & gt;7 (rs855791) with functional iron deficiency and its effect on multiple sclerosis risk in the South African population 〈 /strong 〉 〈 /p 〉 〈 p 〉 K Moremi, S J van Rensburg, L R Fisher, W Davis, F J Cronje, M Jalali Sefid Dashti, J Gamieldien, D Geiger, M Rensburg, R van Toorn, M J de Klerk, G M Hon, T Matsha, S Hassan, R T Erasmus, M Kidd, M J Kotze 〈 /p 〉 〈 p 〉 〈 strong 〉 88. Identifying molecular mechanisms of apormophine-induced addictive behaviours 〈 /strong 〉 〈 /p 〉 〈 p 〉 Z Ndlazi, W Daniels, M Mabandla 〈 /p 〉 〈 p 〉 〈 strong 〉 89. Effects of lifestyle factors and biochemistry on the major neck blood vessels in patients with mutiple sclerosis 〈 /strong 〉 〈 /p 〉 〈 p 〉 M Nelson, S J van Rensburg, M J Kotze, F Isaacs, S Hassan 〈 /p 〉 〈 p 〉 〈 strong 〉 90. Nicotine protects against dopamine neurodegenration and improves motor deficits in a Parkinsonian rat model 〈 /strong 〉 〈 /p 〉 〈 p 〉 N Ngema, P Ngema, M Mabandla, W Daniels 〈 /p 〉 〈 p 〉 〈 strong 〉 91. Cognition: Probing anatomical substrates 〈 /strong 〉 〈 /p 〉 〈 p 〉 H Nowbath 〈 /p 〉 〈 p 〉 〈 strong 〉 92. Chronic exposure to light reverses the effects of maternal separation on the rat prefrontal cortex 〈 /strong 〉 〈 /p 〉 〈 p 〉 V Russel, J Dimatelis 〈 /p 〉 〈 p 〉 〈 strong 〉 93. Evaluating a new drug to combat Alzheimer's disease 〈 /strong 〉 〈 /p 〉 〈 p 〉 S Sibiya, W M U Daniels, M V Mabandla 〈 /p 〉 〈 p 〉 〈 strong 〉 94. Structural brain changes in HIV-infected women with and without childhood trauma 〈 /strong 〉 〈 /p 〉 〈 p 〉 G Spies, F Ahmed, C Fennema-Notestine, S Archibald, S Seedat 〈 /p 〉 〈 p 〉 〈 strong 〉 95. Nicotine-stimulated release of hippocampal norepinephrine is reduced in an animal model of attention-deficit/ hyperactivity disorder: the spontaneously hypertensive rat 〈 /strong 〉 〈 /p 〉 〈 p 〉 T Sterley 〈 /p 〉 〈 p 〉 〈 strong 〉 96. Brain-derive neurotrophic factor (BDNF) protein levels in anxiety disorders: Systematic review and meta-regression analysis 〈 /strong 〉 〈 /p 〉 〈 p 〉 S Suliman, S M J Hemmings, S Seedat 〈 /p 〉 〈 p 〉 〈 strong 〉 97. A 12-month retrospective audit of the demographic and clinical profile of mental healthcare users admitted to a district level hospital in the Western Cape, South Africa 〈 /strong 〉 〈 /p 〉 〈 p 〉 E Thomas, K J Cloete, M Kidd, H Lategan 〈 /p 〉 〈 p 〉 〈 strong 〉 98. Magnesium recurarization: A comparison between reversal of neuromuscular block with sugammadex v. neostigmine/ glycopyrrolate in an 〈 em 〉 in vivo 〈 /em 〉 rat model 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 〈 /strong 〉 M van den Berg, M F M James, L A Kellaway 〈 /p 〉 〈 p 〉 〈 strong 〉 99. Identification of breast cancer patients at increased risk of 'chemobrain': Case study and review of the literature 〈 /strong 〉 〈 /p 〉 〈 p 〉 N van der Merwe, R Pienaar, S J van Rensburg, J Bezuidenhout, M J Kotze 〈 /p 〉 〈 p 〉 〈 strong 〉 100. The protective role of HAART and NAZA in HIV Tat protein-induced hippocampal cell death 〈 /strong 〉 〈 /p 〉 〈 p 〉 S Zulu, W M U Daniels, M V Mabandla 〈 /p 〉

Type of Medium: Online Resource

ISSN: 2078-6786 , 1608-9685

URL: Article

DOI: 10.4102/sajpsychiatry.v19i3.473

Language: Unknown

Publisher: AOSIS

Publication Date: 2013

detail.hit.zdb_id: 2259991-5

In: Journal of Science and Medicine in Sport, Elsevier BV, Vol. 24, No. 12 ( 2021-12), p. 1218-1223

Type of Medium: Online Resource

ISSN: 1440-2440

URL: Article

DOI: 10.1016/j.jsams.2021.06.010

Language: English

Publisher: Elsevier BV

Publication Date: 2021

detail.hit.zdb_id: 2230157-4

In: The Journal of Sports Medicine and Physical Fitness, Edizioni Minerva Medica, Vol. 63, No. 6 ( 2023-05)

Type of Medium: Online Resource

ISSN: 0022-4707 , 1827-1928

URL: Article

DOI: 10.23736/S0022-4707.23.14253-8

Language: English

Publisher: Edizioni Minerva Medica

Publication Date: 2023

SSG: 31

In: Medicine & Science in Sports & Exercise, Ovid Technologies (Wolters Kluwer Health), Vol. 51, No. 6S ( 2019-6), p. 710-710

Type of Medium: Online Resource

ISSN: 1530-0315 , 0195-9131

URL: Article

DOI: 10.1249/01.mss.0000562614.32200.2a

Language: English

Publisher: Ovid Technologies (Wolters Kluwer Health)

Publication Date: 2019

detail.hit.zdb_id: 2031167-9

SSG: 31

In: The Physician and Sportsmedicine, Informa UK Limited, Vol. 50, No. 4 ( 2022-07-04), p. 359-368

Type of Medium: Online Resource

ISSN: 0091-3847 , 2326-3660

URL: Article

DOI: 10.1080/00913847.2021.1932632

Language: English

Publisher: Informa UK Limited

Publication Date: 2022

detail.hit.zdb_id: 2095106-1

SSG: 31

In: Medicine & Science in Sports & Exercise, Ovid Technologies (Wolters Kluwer Health), Vol. 49, No. 5S ( 2017-05), p. 861-

Type of Medium: Online Resource

ISSN: 0195-9131

URL: Article

DOI: 10.1249/01.mss.0000519326.52302.3c

Language: English

Publisher: Ovid Technologies (Wolters Kluwer Health)

Publication Date: 2017

detail.hit.zdb_id: 2031167-9

SSG: 31

In: South African Family Practice, AOSIS, Vol. 60, No. 5 ( 2018-10-23), p. 7-16

Abstract: Skeletal muscle relaxants (SMRs) consist of a heterogeneous group of medications with a side effect profile of concern. The aim of this paper was to review the evidence of use of SMRs in the treatment of sports injuries. A literature search between 2005 – 2018 (Ovid MEDLINE, SPORTDiscus and SCOPUS) were conducted. In addition, citations within articles were searched, and the most commonly prescribed SMRs in South Africa were also used to explore the literature for additional publications. Relevant studies that met the inclusion criteria were selected. Clinical recommendations for general practitioners are given based on the Strength of Recommendation Taxonomy (SORT) level of evidence. Combination drugs rather than single agents are mostly used, however the effectiveness of SMR agents, single and in combination, as well as its significance as opposed to analgesics and non-steroidal anti-inflammatory drugs, still has to be evaluated. Evidence suggest SMRs to be probably effective for use in non-specific lower back pain (acute and chronic lower back muscle strains, ligament sprains, soft tissue contusions), as well as for whiplash associated disorder, mechanical neck disorders, piriformis syndrome, lateral epicondylosis, and plantar fasciitis. It does not appear if there is a role for SMRs as part of combination management for acute cervical strains, post-exercise muscle soreness or myofacial pain syndrome. However, substantial evidence to confirm the use of SMRs in the treatment of sports injuries have not been adequately investigated and is currently largely based on case reports and general reviews.

Type of Medium: Online Resource

ISSN: 2078-6204 , 2078-6190

URL: Article

DOI: 10.4102/safp.v60i5.4912

Language: Unknown

Publisher: AOSIS

Publication Date: 2018

detail.hit.zdb_id: 2162129-9

In: BMC Public Health, Springer Science and Business Media LLC, Vol. 17, No. 1 ( 2017-12)

Type of Medium: Online Resource

ISSN: 1471-2458

URL: Article

DOI: 10.1186/s12889-017-4825-3

Language: English

Publisher: Springer Science and Business Media LLC

Publication Date: 2017

detail.hit.zdb_id: 2041338-5

In: African Journal of Primary Health Care & Family Medicine, AOSIS, Vol. 10, No. 1 ( 2018-05-30)

Abstract: Background: Tuberculosis (TB) prevention, including infection control, is a key element in the strategy to end the global TB epidemic. While effective infection control requires all health system components to function well, this is an area that has not received sufficient attention inSouth Africa despite the availability of policy and guidelines.Aim: To describe the state of implementation of TB infection control measures in a high-burden metro in South Africa.Setting: The research was undertaken in a high TB- and HIV-burdened metropolitan area of South Africa. More specifically, the study sites were primary health care facilities (PHC), thatamong other services also diagnosed TB.Methods: A cross-sectional survey, focusing on the World Health Organization levels of infection control, which included structured interviews with nurses providing TB diagnosis and treatment services as well as observations, at all 41 PHC facilities in a high TB-burdened and HIV-burdened metro of South Africa.Results: Tuberculosis infection control was poorly implemented, with few facilities scoring 80% and above on compliance with infection control measures. Facility controls: 26 facilities (63.4%) had an infection control committee and 12 (29.3%) had a written infection control plan. Administrative controls: 26 facilities (63.4%) reported separating coughing and noncoughing patients, while observations revealed that only 11 facilities (26.8%) had separate waiting areas for (presumptive) TB patients. Environmental controls: most facilities used open windows for ventilation (n = 30; 73.2%); however, on the day of the visit, only 12 facilities (30.3%) had open windows in consulting rooms. Personal protective equipment: 9 facilities (22%) did not have any disposable respirators in stock and only 9 respondents (22%) had undergone fit testing. The most frequently reported barrier to implementing good TBinfection control practices was lack of equipment (n = 22; 40%) such as masks and disposable respirators, as well as the structure or layout of the PHC facilities. The main recommendation to improve TB infection control was education for patients and health care workers (n = 18; 33.3%).Conclusion: All levels of the health care system should be engaged to address TB prevention and infection control in PHC facilities. Improved infection control will address the nosocomial spread of TB in health facilities and keep health care workers and patients safe from infection.

Type of Medium: Online Resource

ISSN: 2071-2936 , 2071-2928

URL: Article

DOI: 10.4102/phcfm.v10i1.1628

Language: Unknown

Publisher: AOSIS

Publication Date: 2018

detail.hit.zdb_id: 2526836-3

SSG: 6,31

In: South African Journal of Psychiatry, AOSIS, Vol. 14, No. 3 ( 2008-08-01), p. 18-

Abstract: 〈 p 〉 〈 strong 〉 1. How can we maintain a sustainable private practice in the current political and economic climate? 〈 /strong 〉 〈 /p 〉 〈 p 〉 Eugene Allers 〈 /p 〉 〈 p 〉 〈 strong 〉 2. SASOP Clinical guidelines, protocols and algorithms: Development of treatment guidelines for bipolar mood disorder and major depression 〈 /strong 〉 〈 /p 〉 〈 p 〉  Eugene Allers, Margaret Nair, Gerhard Grobler 〈 /p 〉 〈 p 〉 〈 strong 〉 3. The revolving door phenomenon in psychiatry: Comparing low-frequency and high-frequency users of psychiatric inpatient services in a developing country 〈 /strong 〉 〈 /p 〉 〈 p 〉 U A Botha, P Oosthuien, L Koen, J A Joska, J Parker, N Horn 〈 /p 〉 〈 p 〉 〈 strong 〉 4. Neurophysiology of emotion and senses - The interface between psyche and soma 〈 /strong 〉 〈 /p 〉 〈 p 〉 Eugene Allers 〈 /p 〉 〈 p 〉 〈 strong 〉 5. Suicide prevention: From and beyond the psychiatrist's hands 〈 /strong 〉 〈 /p 〉 〈 p 〉 O Alonso Betanourt, M Morales Herrera 〈 /p 〉 〈 p 〉 〈 strong 〉 6. Treatment of first-episod psychosis: Efficacy and toleabilty of a long-acting typical antipsychotic 〈 /strong 〉 〈 /p 〉 〈 p 〉 B Chiliza, R Schoeman, R Emsey, P Oosthuizen, L KOen, D Niehaus, S Hawkridge 〈 /p 〉 〈 p 〉 〈 strong 〉 7. Treatment of attention deficit hyperactivity disorder in the young child 〈 /strong 〉 〈 /p 〉 〈 p 〉 Helen Clark 〈 /p 〉 〈 p 〉 〈 strong 〉 8. Holistic/ Alternative treatment in psychiatry: The value of indigenous knowledge systems in cllaboration with moral, ethical and religious approaches in the military services 〈 /strong 〉 〈 /p 〉 〈 p 〉 J Dill 〈 /p 〉 〈 p 〉 〈 strong 〉 9. Treating Schizophrenia: Have we got it wrong? 〈 /strong 〉 〈 /p 〉 〈 p 〉 Robin Emsley 〈 /p 〉 〈 p 〉 〈 strong 〉 10.Terminal questions in the elderly 〈 /strong 〉 〈 /p 〉 〈 p 〉 Mike Ewart Smith 〈 /p 〉 〈 p 〉 〈 strong 〉 11. Mental Health Policy development and implementation in Ghana, South Africa, Uganda and Zambia 〈 /strong 〉 〈 /p 〉 〈 p 〉 Alan J Flisher, Crick Lund, Michelle Frank, Arvin Bhana, Victor Doku, Natalie Drew, Fred N Kigozi, Martin Knapp, Mayeh Omar, Inge Petersen, Andrew Green andthe MHaPP Research Programme Consortium 〈 /p 〉 〈 p 〉 〈 strong 〉 12. What indicators should be used to monitor progress in scaling uo services for people with mental disorders? 〈 /strong 〉 〈 /p 〉 〈 p 〉 Lancet Global Mental Health Group (Alan J Flisher, Dan Chisholm, Crick Lund, Vikram Patel, Shokhar Saxena, Graham Thornicroft, Mark Tomlinson) 〈 /p 〉 〈 p 〉 〈 strong 〉 13. Does unipolar mania merit research in South Africa? A look at the literature 〈 /strong 〉 〈 /p 〉 〈 p 〉 Christoffel Grobler 〈 /p 〉 〈 p 〉 〈 strong 〉 14. Revisiting the Cartesian duality of mind and body 〈 /strong 〉 〈 /p 〉 〈 p 〉 Oye Gureje 〈 /p 〉 〈 p 〉 〈 strong 〉 15. Child and adolescent psychopharmacology: Current trends and complexities 〈 /strong 〉 〈 /p 〉 〈 p 〉 S M Hawkridge 〈 /p 〉 〈 p 〉 〈 strong 〉 16. Integrating mental illness, suicide and religion 〈 /strong 〉 〈 /p 〉 〈 p 〉 Volker Hitzeroth 〈 /p 〉 〈 p 〉 〈 strong 〉 17. Cost of acute inpatient mental health care in a 72-hour assessment uniy 〈 /strong 〉 〈 /p 〉 〈 p 〉 A B R Janse van Rensburg, W Jassat 〈 /p 〉 〈 p 〉 〈 strong 〉 18. Management of Schizophrenia according to South African standard treatment guidelines 〈 /strong 〉 〈 /p 〉 〈 p 〉 A B R Janse van Rensburg 〈 /p 〉 〈 p 〉 〈 strong 〉 19. Structural brain imaging in the clinical management of psychiatric illness 〈 /strong 〉 〈 /p 〉 〈 p 〉 F Y Jeenah 〈 /p 〉 〈 p 〉 〈 strong 〉 20. ADHD: Change in symptoms from child to adulthood 〈 /strong 〉 〈 /p 〉 〈 p 〉 S A Jeeva, A Turgay 〈 /p 〉 〈 p 〉 〈 strong 〉 21. HIV-Positive psychiatric patients in antiretrovirals 〈 /strong 〉 〈 /p 〉 〈 p 〉 G Jonsson, F Y Jeenah, M Y H Moosa 〈 /p 〉 〈 p 〉 〈 strong 〉 22. A one year review of patients admitted to tertiary HIV/Neuropsychiatry beds in the Western Cape 〈 /strong 〉 〈 /p 〉 〈 p 〉 John Joska, Paul Carey, Ian Lewis, Paul Magni, Don Wilson, Dan J Stein 〈 /p 〉 〈 p 〉 〈 strong 〉 23. Star'd - Critical review and treatment implications 〈 /strong 〉 〈 /p 〉 〈 p 〉 Andre Joubert 〈 /p 〉 〈 p 〉 〈 strong 〉 24. Options for treatment-resistent depression: Lessons from Star'd; an interactive session 〈 /strong 〉 〈 /p 〉 〈 p 〉 Andre Joubert 〈 /p 〉 〈 p 〉 〈 strong 〉 25. My brain made me do it: How Neuroscience may change the insanity defence 〈 /strong 〉 〈 /p 〉 〈 p 〉 Sean Kaliski 〈 /p 〉 〈 p 〉 〈 strong 〉 26. Child andadolescent mental health services in four African countries 〈 /strong 〉 〈 /p 〉 〈 p 〉 Sharon Kleintjies, Alan Flisher, Victoruia Campbell-Hall, Arvin Bhana, Phillippa Bird, Victor Doku, Natalie, Drew, Michelle Funk, Andrew Green, Fred Kigozi, Crick Lund, Angela Ofori-Atta, Mayeh Omar, Inge Petersen, Mental Health and Poverty Research Programme Consortium 〈 /p 〉 〈 p 〉 〈 strong 〉 27. Individualistic theories of risk behaviour 〈 /strong 〉 〈 /p 〉 〈 p 〉 Liezl Kramer, Volker Hitzeroth 〈 /p 〉 〈 p 〉 〈 strong 〉 28. Development and implementation of mental health poliy and law in South Africa: What is the impact of stigma? 〈 /strong 〉 〈 /p 〉 〈 p 〉 Ritsuko Kakuma, Sharon Kleintjes, Crick Lund, Alan J Flisher, Paula Goering, MHaPP Research Programme Consortium 〈 /p 〉 〈 p 〉 〈 strong 〉 29. Factors contributing to community reintegration of long-term mental health crae users of Weskoppies Hospital 〈 /strong 〉 〈 /p 〉 〈 p 〉 Carri Lewis, Christa Kruger 〈 /p 〉 〈 p 〉 〈 strong 〉 30. Mental health and poverty: A systematic review of the research in low- and middle-income countries 〈 /strong 〉 〈 /p 〉 〈 p 〉 Crick Lund, Allison Breen, Allan J Flisher, Ritsuko Kakuma, Leslie Swartz, John Joska, Joanne Corrigall, Vikram Patel, MHaPP Research Programe Consortium 〈 /p 〉 〈 p 〉 〈 strong 〉 31. The cost of scaling up mental health care in low- and middle-income countries 〈 /strong 〉 〈 /p 〉 〈 p 〉 Crick Lund, Dan Chishlom, Shekhar Saxena 〈 /p 〉 〈 p 〉 〈 strong 〉 32. 'Tikking'Clock: The impact of a methamphetamine epidemic at a psychiatric hospital in the Western Cape 〈 /strong 〉 〈 /p 〉 〈 p 〉 P Milligan, J S Parker 〈 /p 〉 〈 p 〉 〈 strong 〉 33. Durban youth healh-sk behaviour: Prevalence f Violence-related behaviour 〈 /strong 〉 〈 /p 〉 〈 p 〉 D L Mkize 〈 /p 〉 〈 p 〉 〈 strong 〉 34. Profile of morality of patients amitted Weskoppies Psychiatric Hospital in Sout frican over a 5-Year period (2001-2005) 〈 /strong 〉 〈 /p 〉 〈 p 〉 N M Moola, N Khamker, J L Roos, P Rheeder 〈 /p 〉 〈 p 〉 〈 strong 〉 35. One flew over Psychiatry nest 〈 /strong 〉 〈 /p 〉 〈 p 〉 Leverne Mountany 〈 /p 〉 〈 p 〉 〈 strong 〉 36. The ethical relationship betwe psychiatrists and the pharmaceutical indutry 〈 /strong 〉 〈 /p 〉 〈 p 〉 Margaret  G Nair 〈 /p 〉 〈 p 〉 〈 strong 〉 37. Developing the frameor of a postgraduate da programme in mental health 〈 /strong 〉 〈 /p 〉 〈 p 〉 R J Nichol, B de Klerk, M M Nel, G van Zyl, J Hay 〈 /p 〉 〈 p 〉 〈 strong 〉 38. An unfolding story: The experience with HIV-ve patients at a Psychiatric Hospital 〈 /strong 〉 〈 /p 〉 〈 p 〉 J S Parker, P Milligan 〈 /p 〉 〈 p 〉 〈 strong 〉 39. Task shifting: A practical strategy for scalingup mental health care in developing countries 〈 /strong 〉 〈 /p 〉 〈 p 〉 Vikram Patel 〈 /p 〉 〈 p 〉 〈 strong 〉 40. Ethics: Informed consent and competency in the elderly 〈 /strong 〉 〈 /p 〉 〈 p 〉 Willie Pienaar 〈 /p 〉 〈 p 〉 〈 strong 〉 41. Confronting ommonmoral dilemmas. Celebrating uncertainty, while in search  patient good 〈 /strong 〉 〈 /p 〉 〈 p 〉 Willie Pienaar 〈 /p 〉 〈 p 〉 〈 strong 〉 42. Moral dilemmas in the treatment and repatriation of patients with psychtorders while visiting our country 〈 /strong 〉 〈 /p 〉 〈 p 〉 Duncan Ian Rodseth 〈 /p 〉 〈 p 〉 〈 strong 〉 43. Geriatrics workshop (Psegal symposium): Medico-legal issuess in geriatric psyhiatry 〈 /strong 〉 〈 /p 〉 〈 p 〉 Felix Potocnik 〈 /p 〉 〈 p 〉 〈 strong 〉 44. Brain stimulation techniques - update on recent research 〈 /strong 〉 〈 /p 〉 〈 p 〉 P J Pretorius 〈 /p 〉 〈 p 〉 〈 strong 〉 45. Holistic/Alternative treatments in psychiatry 〈 /strong 〉 〈 /p 〉 〈 p 〉 T Rangaka, J Dill 〈 /p 〉 〈 p 〉 〈 strong 〉 46. Cognitive behaviour therapy and other brief interventions for management of substances 〈 /strong 〉 〈 /p 〉 〈 p 〉 Solomon Rataemane 〈 /p 〉 〈 p 〉 〈 strong 〉 47. A Transtheoretical view of change 〈 /strong 〉 〈 /p 〉 〈 p 〉 Nathan P Rogerson 〈 /p 〉 〈 p 〉 〈 strong 〉 48. Profile of security breaches in longerm mental health care users at Weskoppies Hospital over a 6-month period 〈 /strong 〉 〈 /p 〉 〈 p 〉 Deleyn Rema, Lindiwe Mthethwa, Christa Kruger 〈 /p 〉 〈 p 〉 〈 strong 〉 49. Management of psychogenic and chronic pain - A novel approach 〈 /strong 〉 〈 /p 〉 〈 p 〉 M S Salduker 〈 /p 〉 〈 p 〉 〈 strong 〉 50. Childhood ADHD and bipolar mood disorders: Differences and similarities 〈 /strong 〉 〈 /p 〉 〈 p 〉 L Scribante 〈 /p 〉 〈 p 〉 〈 strong 〉 51. The choice of antipsychotic in HIV-infected patients and psychopharmacocal responses to antipsychotic medication 〈 /strong 〉 〈 /p 〉 〈 p 〉 Dinesh Singh, Karl Goodkin 〈 /p 〉 〈 p 〉 〈 strong 〉 52. Pearls in clinical neuroscience: A teaching column in CNS Spectrums 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 〈 /strong 〉 Dan J Stein 〈 /p 〉 〈 p 〉 〈 strong 〉 53. Urinary Cortisol secretion and traumatics in a cohort of SA Metro policemen A longitudinal study 〈 /strong 〉 〈 /p 〉 〈 p 〉 Ugash Subramaney 〈 /p 〉 〈 p 〉 〈 strong 〉 54. Canabis use in Psychiatric inpatients 〈 /strong 〉 〈 /p 〉 〈 p 〉 〈 strong 〉 〈 /strong 〉 M Talatala, G M Nair, D L Mkize 〈 /p 〉 〈 p 〉 〈 strong 〉 55. Pathways to care and treatmt in first and multi-episodepsychosis: Findings fm a developing country 〈 /strong 〉 〈 /p 〉 〈 p 〉 H S Teh, P P Oosthuizen 〈 /p 〉 〈 p 〉 〈 strong 〉 56. Mental disorders in HIV-infected indivat various HIV Treatment sites in South Africa 〈 /strong 〉 〈 /p 〉 〈 p 〉 Rita Thom 〈 /p 〉 〈 p 〉 〈 strong 〉 57. Attendanc ile of long-term mental health care users at ocupational therapy group sessions at Weskoppies Hospital 〈 /strong 〉 〈 /p 〉 〈 p 〉 Ronel van der Westhuizen, Christa Kruger 〈 /p 〉 〈 p 〉 〈 strong 〉 58. Epidemiological patterns of extra-medical drug use in South Africa: Results from the South African stress and health study 〈 /strong 〉 〈 /p 〉 〈 p 〉 Margaretha S van Heerden, Anna Grimsrud, David Williams, Dan  Stein 〈 /p 〉 〈 p 〉 〈 strong 〉 59. Persocentred diagnosis: Where d ps and mental disorders fit in the International classificaton of diseases (ICD)? 〈 /strong 〉 〈 /p 〉 〈 p 〉 Werdie van Staden 〈 /p 〉 〈 p 〉 〈 strong 〉 60. What every psychiatrist needs to know about scans 〈 /strong 〉 〈 /p 〉 〈 p 〉 Herman van Vuuren 〈 /p 〉 〈 p 〉 〈 strong 〉 61. Psychiatric morbidity in health care workers withle drug-resistant erulosis (MDR-TB) A case series 〈 /strong 〉 〈 /p 〉 〈 p 〉 Urvashi Vasant, Dinesh Singh 〈 /p 〉 〈 p 〉 〈 strong 〉 62. Association between uetrine artery pulsatility index and antenatal maternal psychological stress 〈 /strong 〉 〈 /p 〉 〈 p 〉 Bavanisha Vythilingum, Lut Geerts, Annerine Roos, Sheila Faure, Dan J Stein 〈 /p 〉 〈 p 〉 〈 strong 〉 63. Approaching the dual diagnosis dilemma 〈 /strong 〉 〈 /p 〉 〈 p 〉 Lize Weich 〈 /p 〉 〈 p 〉 〈 strong 〉 64. Women's mental health: Onset of mood disturbance in midlife - Fact or fiction 〈 /strong 〉 〈 /p 〉 〈 p 〉 Denise White 〈 /p 〉 〈 p 〉 〈 strong 〉 65. Failing or faking: Isses in the fiagnosis and treatment of adult ADHD 〈 /strong 〉 〈 /p 〉 〈 p 〉 Dora Wynchank 〈 /p 〉

Type of Medium: Online Resource

ISSN: 2078-6786 , 1608-9685

URL: Article

DOI: 10.4102/sajpsychiatry.v14i3.165

Language: Unknown

Publisher: AOSIS

Publication Date: 2008

detail.hit.zdb_id: 2259991-5